Evidence map›Paper›PMID 32134364›Full record

ArticleCirculation research2020

Hyperglycemia Acutely Increases Cytosolic Reactive Oxygen Species via

Shan Lu, Zhandi Liao, Xiyuan Lu, Dörthe M Katschinski, Mark Mercola, Ju Chen, Joan Heller Brown, Jeffery D Molkentin, Julie Bossuyt, Donald M Bers

Open access · bronzeAbstract read
In one paragraph

Article in Circulation research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 96 papers.

0numbers the graph read from it
0cells of the map it votes in
96citing papers in PubMed
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

96 citing papers in PubMed, 140 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. PerturbingCells · 2026
    Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review

36 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 3 countries.

Shan LuFrom the Department of Pharmacology, University of California, Davis School of Medicine (S.L., Z.L., J.B., D.M.B.).
Zhandi LiaoFrom the Department of Pharmacology, University of California, Davis School of Medicine (S.L., Z.L., J.B., D.M.B.).
Xiyuan LuDepartment of Cardiology, Renji Hospital School of Medicine, Jiaotong University, Shanghai, China (X.L.).
Dörthe M KatschinskiInstitute of Cardiovascular Physiology, University Medical Centre Göttingen, Germany (D.M.K.).
Mark MercolaStanford Cardiovascular Institute and Department of Medicine, Stanford University, CA (M.M.).
Ju ChenDepartment of Medicine (J.C.), University of California San Diego, La Jolla.
Joan Heller BrownDepartment of Pharmacology (J.H.B.), University of California San Diego, La Jolla.
Jeffery D MolkentinDepartment of Pediatrics, University of Cincinnati, Cincinnati Children's Hospital Medical Center, OH (J.D.M.).
Julie BossuytFrom the Department of Pharmacology, University of California, Davis School of Medicine (S.L., Z.L., J.B., D.M.B.).
Donald M BersFrom the Department of Pharmacology, University of California, Davis School of Medicine (S.L., Z.L., J.B., D.M.B.).
University of California, Davis · USUniversity of California San Diego · USCardiovascular Institute of the South · USCincinnati Children's Hospital Medical Center · USGerman Centre for Cardiovascular Research · DERenji Hospital · CN

Funding

Project 3 (Mercola)P01HL141084 · NHLBI · STANFORD UNIVERSITY · PI Joseph C. Wu · 2019 to 2026
$21.1M
Pathophysiological Regulation of Cardiac Myocyte RyR ChannelR01HL092097 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Donald M Bers, Robyn T Rebbeck · 2010 to 2026
$9.3M
Training Program In Basic & Translational Cardiovascular ScienceT32HL086350 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Martin Cadeiras, David A. Liem · 2008 to 2026
$7.1M
Molecular examination of mitochondrial calcium controlR01HL132831 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI BERS, DONALD M, MOLKENTIN, JEFFERY D · 2016 to 2024
$5.9M
CaMKII activation and regulation in adult cardiac myocytesR01HL142282 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BERS, DONALD M, BOSSUYT, JULIE B · 2018 to 2025
$5.4M
IONIC CONTROL OF CARDIAC MUSCLE CONTRACTION: EC COUPLINGR01HL030077 · NHLBI · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI BERS, DONALD M · 1986 to 2018
$3.8M
Cardiomyocyte CaM kinase II as a driver of cardiac inflammation and remodelingR01HL145459 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BROWN, JOAN HELLER, MIYAMOTO, SHIGEKI · 2019 to 2022
$1.6M
NHLBI NIH HHS P01 HL141084NHLBI NIH HHS R01 HL030077NHLBI NIH HHS R01 HL092097NHLBI NIH HHS R01 HL132831NHLBI NIH HHS R01 HL142282NHLBI NIH HHS R01 HL145459NHLBI NIH HHS T32 HL086350
6 · The paper itself

Abstract

rationaleDiabetes mellitus is a complex, multisystem disease, affecting large populations worldwide. Chronic CaMKII (Ca

objectiveTo test whether high extracellular glucose (Hi-Glu) promotes ventricular myocyte ROS generation and the role played by CaMKII. METHODS AND

resultsWe tested how extracellular Hi-Glu influences ROS production in adult ventricular myocytes, using DCF (2',7'-dichlorodihydrofluorescein diacetate) and genetically targeted Grx-roGFP2 redox sensors. Hi-Glu (30 mmol/L) significantly increased the rate of ROS generation-an effect prevented in myocytes pretreated with CaMKII inhibitor KN-93 or from either global or cardiac-specific CaMKIIδ KO (knockout) mice. CaMKII KO or inhibition also prevented Hi-Glu-induced sarcoplasmic reticulum Ca

conclusionsDiabetic hyperglycemia induces acute cardiac myocyte ROS production by NOX2 that requires

Indexed as

AnimalsCalcium-Calmodulin-Dependent Protein Kinase Type 2Calcium SignalingCells, CulturedDiabetic CardiomyopathiesEnzyme ActivationGlucoseGlutaredoxinsGlycosylationHumansHyperglycemiaInduced Pluripotent Stem CellsMice, Inbred C57BLMice, KnockoutMyocytes, CardiacNADPH Oxidase 2Calcium-Calmodulin-Dependent Protein Kinase Type 2Camk2d protein, mouseCybb protein, mouseGlrx protein, mouseGlucoseGlutaredoxinsNADPH Oxidase 2Reactive Oxygen Speciescalcium-calmodulin-dependent protein kinase type 2hyperglycemiamyocytes, cardiacoxidation-reductionsignal transduction

Identifiers

PMID32134364
PMCPMC7210078
OpenAlexW3011404862

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.